Sharp Edge Labs, a Carnegie Mellon University spin-out, is a life sciences firm that develops small-molecule drugs to tackle genetic diseases.
Member count: 11-50
Investors 1
Date | Name | Website |
- | Newlin Inv... | newlininve... |
Date | Name | Website |
- | Newlin Inv... | newlininve... |